Europe Organoids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Organoids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Organoids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Organoids Market Regional Analysis

6.2 Europe Organoids Market Revenue 2021-2031 (US$ Million)

6.3 Europe Organoids Market Forecast Analysis

7. Europe Organoids Market Analysis – by Type

7.1 Intestine

7.1.1 Overview
7.1.2 Intestine: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Liver

7.2.1 Overview
7.2.2 Liver: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Stomach

7.3.1 Overview
7.3.2 Stomach: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Pancreas

7.4.1 Overview
7.4.2 Pancreas: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Lung

7.5.1 Overview
7.5.2 Lung: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Brain

7.6.1 Overview
7.6.2 Brain: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Kidney

7.7.1 Overview
7.7.2 Kidney: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Others

7.8.1 Overview
7.8.2 Others : Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Organoids Market Analysis – by Application

8.1 Developmental Biology Disease

8.1.1 Overview
8.1.2 Developmental Biology Disease: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Pathology of Infectious Disease

8.2.1 Overview
8.2.2 Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Regenerative Medicine

8.3.1 Overview
8.3.2 Regenerative Medicine: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Drug Toxicity and Efficacy Testing

8.4.1 Overview
8.4.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Drug Discovery and Personalized Medicine

8.5.1 Overview
8.5.2 Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Others

8.6.1 Overview
8.6.2 Others: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Organoids Market Analysis – by Source

9.1 Pluripotent Stem Cells

9.1.1 Overview
9.1.2 Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Organ-Specific Adult Stem Cell

9.2.1 Overview
9.2.2 Organ-Specific Adult Stem Cell: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Organoids Market Analysis – by Offering

10.1 Instruments

10.1.1 Overview
10.1.2 Instruments: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Consumables

10.2.1 Overview
10.2.2 Consumables: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Services

10.3.1 Overview
10.3.2 Services: Europe Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Organoids Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Organoids Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 Europe Organoids Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 UK: Europe Organoids Market Breakdown, by Type
11.2.1.1.2 UK: Europe Organoids Market Breakdown, by Application
11.2.1.1.3 UK: Europe Organoids Market Breakdown, by Source
11.2.1.1.4 UK: Europe Organoids Market Breakdown, by Offering

11.2.1.2 Germany: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Germany: Europe Organoids Market Breakdown, by Type
11.2.1.2.2 Germany: Europe Organoids Market Breakdown, by Application
11.2.1.2.3 Germany: Europe Organoids Market Breakdown, by Source
11.2.1.2.4 Germany: Europe Organoids Market Breakdown, by Offering

11.2.1.3 France: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 France: Europe Organoids Market Breakdown, by Type
11.2.1.3.2 France: Europe Organoids Market Breakdown, by Application
11.2.1.3.3 France: Europe Organoids Market Breakdown, by Source
11.2.1.3.4 France: Europe Organoids Market Breakdown, by Offering

11.2.1.4 Spain: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Spain: Europe Organoids Market Breakdown, by Type
11.2.1.4.2 Spain: Europe Organoids Market Breakdown, by Application
11.2.1.4.3 Spain: Europe Organoids Market Breakdown, by Source
11.2.1.4.4 Spain: Europe Organoids Market Breakdown, by Offering

11.2.1.5 Italy: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Italy: Europe Organoids Market Breakdown, by Type
11.2.1.5.2 Italy: Europe Organoids Market Breakdown, by Application
11.2.1.5.3 Italy: Europe Organoids Market Breakdown, by Source
11.2.1.5.4 Italy: Europe Organoids Market Breakdown, by Offering

11.2.1.6 Rest of Europe: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Organoids Market Breakdown, by Type
11.2.1.6.2 Rest of Europe: Europe Organoids Market Breakdown, by Application
11.2.1.6.3 Rest of Europe: Europe Organoids Market Breakdown, by Source
11.2.1.6.4 Rest of Europe: Europe Organoids Market Breakdown, by Offering

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 STEMCELL Technologies Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Molecular Devices, LLC.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Hubrecht Organoid Technology

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Definigen

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Organoid Therapeutics

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Thermo Fisher Scientific Inc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Corning Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Merck KGaA

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 InSphero

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 ACRO Biosystems

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Bio-Techne Corp

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 SUN bioscience SA

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

14.13 ORGANOID SCIENCES Co., Ltd.

14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments

14.14 Crown Bioscience Inc

14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments

14.15 Sartorius AG

14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments

14.16 3D Biotek LLC

14.16.1 Key Facts
14.16.2 Business Description
14.16.3 Products and Services
14.16.4 Financial Overview
14.16.5 SWOT Analysis
14.16.6 Key Developments

14.17 Prellis Biologics Inc.

14.17.1 Key Facts
14.17.2 Business Description
14.17.3 Products and Services
14.17.4 Financial Overview
14.17.5 SWOT Analysis
14.17.6 Key Developments

14.18 3Dnamics Inc.

14.18.1 Key Facts
14.18.2 Business Description
14.18.3 Products and Services
14.18.4 Financial Overview
14.18.5 SWOT Analysis
14.18.6 Key Developments

14.19 Cellesce Ltd

14.19.1 Key Facts
14.19.2 Business Description
14.19.3 Products and Services
14.19.4 Financial Overview
14.19.5 SWOT Analysis
14.19.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Organoids Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis